Normative Data Base of Brain Network Activation (BNA) Using Evoked Response Potentials (Normative)
Clinical Trial Protocol for the Establishment of Normative Data of Brain Network Activation (BNA) Using Evoked Response Potentials in Adolescents, Young Adults and Adults
Purpose: EEstablish normative data of ElMindA's Brain Network Activation (BNA) using evoked response potentials in adolescents, young adults and Adults.
Trial design: Open, one-arm, prospective, age-stratified, multi site. Enrollment size: Up to 1500 subjects will be enrolled in 4 or more sites. Study duration: Each patient will be followed up for up to 1 year. Overall study duration will be up to 1.5 years. Patient population: Adolescents, young adults and Adults of both genders.
Age range:
- 10-11.99
- 12-13.99
- 14-15.99
- 16-17.99
- 18-24.99
- 25-29.99
- 30-34.99
- 35-39.99
- 40-44.99
- 45-49.99
- 50-54.99
- 55-60
- 60 and above
Objective: Establishment of normative data of BNA.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Currently, there is no reliable, bedside, and non-invasive method for assessing connectivity changes in electrophysiological activity of the brain associated with brain-related pathologies, e.g., concussion, ADHD, autistic spectrum disorders (ASD), etc. Event Related Potentials (ERPs), which are temporal reflections of the neural mass electrical activity of cells in specific regions of the brain that occur in response to stimuli, may offer such a method, as they provide both a non-invasive and portable measure of brain function. The ERPs provide excellent temporal information, but spatial resolution for ERPs has traditionally been limited. However, by using high-density electroencephalograph (EEG) recording spatial resolution for ERPs is improved significantly. The paradigm for the current study will combine neurophysiological knowledge with mathematical signal processing and pattern recognition methods (BNA) to temporally and spatially map brain function, connectivity and synchronization.
The need of objective measures that will help the clinician in its decision making in brain-related pathologies is recognized. BNA is a new imaging modality that has been developed to fill this gap.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Banglore, India, 560092
- Cytespace Research Private Limited
-
-
-
-
Colorado
-
Denver, Colorado, United States, 80209
- Clinical trials of the Rockies, Inc.
-
-
Illinois
-
Skokie, Illinois, United States, 60076
- Psychiatric Medicine Associates, LLC
-
-
Nevada
-
Las Vegas, Nevada, United States, 89104
- Clinical Research Center of Nevada
-
-
Ohio
-
Columbus, Ohio, United States, 43212
- Ohio Clinical Trials, Inc.
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- Age 10-years and above.
- Able to speak, read and understand English sufficiently to understand the nature of the study, and to allow completion of all study assessments.
- Willingness to participate and able to give informed assent (child) and/or consent (parent for minors or adult 18+ years of age for self).
Exclusion criteria:
- Has participated in the past 6 months in an organized contact sport activity (e.g., football, hockey, soccer, rugby, lacrosse, martial arts, Boxing).
- Currently with lice or open wounds on scalp.
- Any chronic disease or condition which affects the nervous system as determined by clinical neurological evaluation, medical history or PI discretion.
- Active (within 1 month) Migraine history or clinically significant reoccurring Migraine episodes.
- Any psychiatric disorder, e.g., depression, bipolar disorder, schizophrenic disorder, etc. as determined by clinical evaluation and the Mini International Neuropsychiatric Interview (MINI)
- Any CNS neurologic disorder, e.g., epilepsy, seizures, etc. as determined by clinical evaluation
- Any neuropsychological disorders, e.g.: ADHD, Autistic Spectrum Disorder (ASD), etc. as determined by clinical evaluation
- History of Special education, e.g., reading disorder (dyslexia), writing disorder (dysgraphia), math disorder (dyscalculia), nonverbal learning disorder.
- History of any medication affecting CNS within the last 3 months, e.g., antidepressants, anticonvulsants, psychostimulants, first generation antihistamines, etc. The investigator should consider including subjects which had used such drugs for a short period according to a logical calculation of the drug's half-life.
- Substance abuse in the last 3 months and any clinically significant substance dependency as determined by the MINI evaluation and PI discretion.
- Significant sensory deficits, e.g., deafness or blindness.
- Pregnant women or women that are 1 month following a childbirth.
- History of any clinically significant brain trauma as determined by the investigator.
- History of more than 1 clinically diagnosed concussion.
- Clinically diagnosed with a concussion in the past year. Minor deviations to eligibility criteria may be made on a case-by-case basis prior to enrollment if approved by the Sponsor, in writing, in agreement with the Investigator.
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Test retest- 2 visits
Eligible participants will arrive for 2 testing visits a week apart and an optional third visit within 6-12 months.
|
|
|
Single Visit
Eligible participants will arrive for a single testing visit
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Developing a BNA database for normative population.
Time Frame: 1.5 years
|
Functional networks of brain activity in healthy individuals measured using analysis of EEG Event Related Potential (ERP) data
|
1.5 years
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- ELM-25
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normative
-
NCT05616975WithdrawnReliability | Validity | Normative Data
-
NCT02105935Completed
-
NCT02004938CompletedUltrasound Measurements | Normative Values
-
NCT03092661UnknownNormative Oxygen Saturation Levels in Infants
-
NCT07567547Not yet recruitingGrip Strength | Normative Values | Ice Hockey Players
-
NCT02279264Unknown
-
NCT06818162Not yet recruitingCollecting Normative Data of Ulnar Nerve CSA
-
NCT01387009CompletedNormative Data Study of Joints of Healthy Children
-
NCT01940289UnknownFoot Pain | Normative Algometric Pressures
-
NCT06776796CompletedAlcohol Use | Personalized Normative Feedback
Clinical Trials on Performint EEG tests and BNA analysis
-
NCT02407496CompletedAttention Deficit Hyperactivity Disorder (ADHD)
-
NCT03865771RecruitingBenign Epilepsy With Centro Temporal Spikes (BECTS) | Atypical Benign Partial Epilepsy (ABPE) | Epileptic Encephalopathy With Continuous Spike and Waves During Sleep (ECSWS)
-
NCT05080491RecruitingAttention Deficit With Hyperactivity Disorder
-
NCT02923323Active, not recruiting
-
NCT02606591TerminatedHealth and Wellness
-
NCT06711042CompletedHip Dislocation | Hip Osteoarthritis | Total Hip Replacement
-
NCT02691338Recruiting
-
NCT07073274CompletedEndoscopy of Stomach (Procedure) | Colonoscopy (Procedure) | Continuous Processed Electroencephalogram (Procedure)
-
NCT06346054RecruitingGastric Cancer | Esophageal Cancer | Barrett Esophagus
-
NCT02236832CompletedHealthy Subjects | Frontotemporal Dementia | Progressive Supranuclear Palsy